Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 21, 2017; 23(47): 8345-8354
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8345
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8345
Table 3 Spearman analysis of correlation between circ-LDLRAD3 and clinicopathological factors of pancreatic cancer patients (ΔCT values in tissues)
Variable | Circ-LDLRAD3 expression level | |
Spearman correlation | P value | |
Age (yr) | -0.22 | 0.243 |
Gender | -0.122 | 0.521 |
Tumor diameter (cm) | -0.303 | 0.104 |
CA19-9 | 0.028 | 0.883 |
CEA | 0.019 | 0.919 |
Clinical stage | -0.415 | 0.022 |
T classification | -0.519 | 0.003 |
N classification | -0.196 | 0.299 |
Metastasis | None | None |
Venous invasion | -0.607 | < 0.001 |
Lymphatic invasion | -0.478 | 0.008 |
- Citation: Yang F, Liu DY, Guo JT, Ge N, Zhu P, Liu X, Wang S, Wang GX, Sun SY. Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. World J Gastroenterol 2017; 23(47): 8345-8354
- URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8345.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i47.8345